Role of oxidative stress and antioxidants in Peyronie’s disease
The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“PD progresses in two main stages. The first phase typically lasts between 12 and 18 months; this phase is the “active inflammatory phase”, in which plaque forms and progresses to fibrosis and potential calcification, accompanied by pain and worsening of the penile deformity. In the second phase, known as the chronic “stabilized phase”, penile pain decreases and the plaque size and deformity stabil”
From Clinical Presentation of Peyronie’s Disease: A Retrospective Study of 564 Cases (2024) · cites this paper as [15]
In the citing paper
“In the scientific literature, several articles have appeared in the 21st century that have clarified the important role that “oxidative stress” plays in the pathophysiology of PD [15,16,17,18,19,20,21,22].”
From Clinical Presentation of Peyronie’s Disease: A Retrospective Study of 564 Cases (2024) · cites this paper as [15]
Citations
Cites
Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly
Beckman, J. S., & Koppenol, W. H. (1996) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1996.271.5.c1424 · Cited by 5,513
Nuclear Factor-κB — A Pivotal Transcription Factor in Chronic Inflammatory Diseases
Barnes, P. J., & Karin, M. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704103361506 · Cited by 4,669
Transforming Growth Factor β in Tissue Fibrosis
Epstein, F. H., Border, W. A., & Noble, N. A. (1994) · New England Journal of Medicine · doi:10.1056/nejm199411103311907 · Cited by 3,069
The chemistry of peroxynitrite: A product from the reaction of nitric oxide with superoxide
Pryor, W. A., & Squadrito, G. L. (1995) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.1995.268.5.l699 · Cited by 1,511
Formation of nitric oxide-derived inflammatory oxidants by myeloperoxidase in neutrophils
Eiserich, J. P., Hristova, M., Cross, C. E., Jones, A. D., Freeman, B. A., Halliwell, B., & van der Vliet, A. (1998) · Nature · doi:10.1038/34923 · Cited by 1,496
Peroxynitrite, a cloaked oxidant formed by nitric oxide and superoxide
Koppenol, W. H., Moreno, J. J., Pryor, W. A., Ischiropoulos, H., & Beckman, J. S. (1992) · Chemical Research in Toxicology · doi:10.1021/tx00030a017 · Cited by 1,338
Relative Impact of Oxidative Stress on Male Reproductive Function
Sikka, S. (2001) · Current Medicinal Chemistry · doi:10.2174/0929867013373039 · Cited by 601 · cited 1×
“13 Knowledge about the role of ROS and oxidative *Correspondence: SC Sikka, Department of Urology, Tulane University Medical School, 1430 Tulane Avenue, SL-42, New Orleans, LA 70112-2699, USA. ssikka@tulane.edu International Journal of Impotence Research (2002) 14, 353–360 2002 Nature Publishing Group All rights reser…”
BackgroundSelf-citationNitric oxide and oxygen radicals: a question of balance
Darley-Usmar, V., Wiseman, H., & Halliwell, B. (1995) · FEBS Letters · doi:10.1016/0014-5793(95)00764-z · Cited by 556
The Natural History of Peyronie’s Disease
Gelbard, M. K., Dorey, F., & James, K. (1990) · Journal of Urology · doi:10.1016/s0022-5347(17)39746-x · Cited by 525
Protein Sulfhydryls and Their Role in the Antioxidant Function of Protein S-Thiolation
Thomas, J. A., Poland, B., & Honzatko, R. (1995) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1995.1261 · Cited by 399
Isoprostanes: Formation, Analysis and Use As Indices of Lipid Peroxidation in Vivo
Lawson, J. A., FitzGerald, G. A., & Rokach, J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.35.24441 · Cited by 381
El-Sakka, A. I., Hassoba, H. M., Pillarisetty, R. J., Dahiya, R., & Lue, T. F. (1997) · Journal of Urology · doi:10.1016/s0022-5347(01)64223-x · Cited by 250
Moreland, R. B., Traish, A., McMillin, M. A., Smith, B., Goldstein, I., & Saenz de Tejada, I. (1995) · Journal of Urology · doi:10.1016/s0022-5347(01)67730-9 · Cited by 246
Intralesional Verapamil Injection for the Treatment of Peyronie’s Disease
Levine, L. A., Merrick, P. F., & Lee, R. C. (1994) · Journal of Urology · doi:10.1016/s0022-5347(17)35291-6 · Cited by 207
PENILE TRAUMA: AN ETIOLOGIC FACTOR IN PEYRONIE'S DISEASE AND ERECTILE DYSFUNCTION
Jarow, J. P., & Lowe, F. C. (1997) · Journal of Urology · doi:10.1016/s0022-5347(01)64222-8 · Cited by 202
Peyronie's Disease: Etiology, Medical, and Surgical Therapy
HELLSTROM, W. J. G., & BIVALACQUA, T. J. (2000) · Journal of Andrology · doi:10.1002/j.1939-4640.2000.tb03387.x · Cited by 170
Self-citationFibrin Deposition in Peyronie's Disease Plaque
Somers, K. D., & Dawson, D. M. (1997) · Journal of Urology · doi:10.1016/s0022-5347(01)65367-9 · Cited by 160
The Treatment of Peyronie's Disease with Tamoxifen
RALPH, D. J., BROOKS, M. D., BOTTAZZO, G. F., & PRYOR, J. P. (1992) · British Journal of Urology · doi:10.1111/j.1464-410x.1992.tb15836.x · Cited by 154
Fibrin Deposition in Peyronie's Disease Plaque
Somers, K. D., & Dawson, D. M. (1997) · The Journal of Urology · doi:10.1097/00005392-199701000-00104 · Cited by 144
Duncan, M. R., Berman, B., & Nseyo, U. O. (1991) · Scandinavian Journal of Urology and Nephrology · doi:10.3109/00365599109024539 · Cited by 132
Nyberg, L. M., Bias, W. B., Hochberg, M. C., & Walsh, P. C. (1982) · Journal of Urology · doi:10.1016/s0022-5347(17)52751-2 · Cited by 110
Is malonaldehyde a valuable indicator of lipid peroxidation?
Bonnes-Taourel, D., Guérin, M.-C., & Torreilles, J. (1992) · Biochemical Pharmacology · doi:10.1016/0006-2952(92)90132-3 · Cited by 108
Factors Associated in the Aetiology of Peyronie's Disease
CHILTON, C. P., CASTLE, W. M., WESTWOOD, C. A., & PRYOR, J. P. (1982) · British Journal of Urology · doi:10.1111/j.1464-410x.1982.tb13640.x · Cited by 106
Handbook of Sexual Dysfunction
(2005) · CRC Press eBooks · doi:10.1201/b14175 · Cited by 103
Isolation and Characterization of Collagen in Peyronie’s Disease
Somers, K. D., Sismour, E. N., Wright, G. L., Devine, C. J., Gilbert, D. A., & Horton, C. E. (1989) · Journal of Urology · doi:10.1016/s0022-5347(17)40920-7 · Cited by 95
THE USE OF TOCOPHEROLS IN THE TREATMENT OF PEYRONIE'S DISEASE
Scardino, P. L., & Scott, W. W. (1949) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1949.tb55300.x · Cited by 91
The distribution of elastic fibrous elements within the human penis
HSU, G. ‐., BROCK, G., HEYDEN, B. V., NUNES, L., LUE, T. F., & TANAGHO, E. A. (1994) · British Journal of Urology · doi:10.1111/j.1464-410x.1994.tb07645.x · Cited by 85
Van De Water, L. (1997) · Journal of Urology · doi:10.1016/s0022-5347(01)65366-7 · Cited by 77
Treatment of Peyronie's Disease with Local lnterferon-a2b
Wegner, H., Andresen, R., Knipsel, H. H., & Miller, K. (1995) · European Urology · doi:10.1159/000475057 · Cited by 72
THE EFFECT OF SURGICAL TRAUMA ON RAT TUNICA ALBUGINEA
EL-SAKKA, A. I., SELPH, C. A., YEN, T. S. B., DAHIYA, R., & LUE, T. F. (1998) · Journal of Urology · doi:10.1097/00005392-199805000-00097 · Cited by 70
Mechanisms of Calcification in Peyronie’s Disease
Berg, J. S. V., Devine, C. J., Horton, C. E., Somers, K. D., Wright, G. L., Leffell, M. S., Dawson, D. M., Gleischman, S. H., & Rowe, M. J. (1982) · Journal of Urology · doi:10.1016/s0022-5347(17)53599-5 · Cited by 69
Superoxide dismutases: regularities and irregularities.
Fridovich, I. (1983) · PubMed · Cited by 69
Increased Serum Levels of Anti-Elastin Antibodies in Patients with Peyronie’s Disease
Stewart, S., Malto, M., Sandberg, L., & Colburn, K. K. (1994) · Journal of Urology · doi:10.1016/s0022-5347(17)32828-8 · Cited by 67
Intralesional interferon in the treatment of Peyronie's disease: a pilot study
Judge, J. S., & Wisniewski, Z. S. (1997) · British Journal of Urology · doi:10.1046/j.1464-410x.1997.02849.x · Cited by 67
Inhibition of Peyronie's plaque fibroblast proliferation by biologic agents
Anderson, M. P., Shankey, T., Lubrano, T., & Mulhall, J. (2000) · International journal of impotence research · doi:10.1038/sj.ijir.3900558 · Cited by 66
The Immunological Features of Peyronie's Disease
Ralph, D. J., Mirakian, R., Pryor, J. P., & Bottazzo, G. F. (1996) · Journal of Urology · doi:10.1016/s0022-5347(01)66582-0 · Cited by 63
AHUJA, S., BIVALACQUA, T. J., CASE, J., VINCENT, M., SJXKA, S. C., & HELLSTROM, W. J. G. (1999) · Journal of Andrology · doi:10.1002/j.1939-4640.1999.tb02539.x · Cited by 60
Self-citationRAJASEKARAN, M., MONDAL, D., AGRAWAL, K., CHEN, I.-L., HELLSTROM, W., & SIKKA, S. (1998) · Journal of Urology · doi:10.1016/s0022-5347(01)62298-5 · Cited by 55
Self-citationIacono, F., Barra, S., De Rosa, G., Boscaino, A., & Lotti, T. (1993) · Journal of Urology · doi:10.1016/s0022-5347(17)35901-3 · Cited by 48
Cell Culture of Peyronie’s Disease Plaque and Normal Penile Tissue
Somers, K. D., Dawson, D. M., Wright, G. L., Leffell, M. S., Rowe, M. J., Bluemink, G. G., Berg, J. S. V., Gleischman, S. H., Devine, C. J., & Horton, C. E. (1982) · Journal of Urology · doi:10.1016/s0022-5347(17)53917-8 · Cited by 45
(1991) · PubMed · Cited by 44
Potassium para-aminobenzoate for the treatment of Peyronie's disease: is it effective?
Carson, C. C. (1997) · PubMed · Cited by 39
Stimulation of collagen production in an in vitro model for Peyronie’s disease
Sk, A., Sikka, S. C., & Hellstrom, W. J. G. (1999) · International Journal of Impotence Research · doi:10.1038/sj.ijir.3900414 · Cited by 35
Self-citationNitric Oxide Induces Oxidative Stress and Mediates Cytotoxicity to Human Cavernosal Cells in Culture
Rajasekaran, M. R., Hellstrom, W. J. G., & Sikka, S. C. (2001) · Journal of Andrology · doi:10.1002/j.1939-4640.2001.tb02150.x · Cited by 32
Self-citationYang, M., & Cederbaum, A. I. (1995) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1995.0041 · Cited by 22
Benson, G. S. (1993) · The Journal of Urology · doi:10.1016/s0022-5347(17)36383-8 · Cited by 14
A stretch-sensitive Cl− channel in human corpus cavernosal myocytes
Fan, S.-F., Christ, G. J., Melman, A., & Brink, P. R. (1999) · International Journal of Impotence Research · doi:10.1038/sj.ijir.3900373 · Cited by 11
POTENTIAL ROLE OF NUCLEAR FACTOR-kappa B IN THE INDUCTION OF PEYRONIE'S-LIKE CONDITION IN THE RAT
Bivalacqua, T. J., Purohit, S. K., Sresthadatta, A., Glass, J. R., Rajasekaran, M. R., Abdel‐Mageed, A. B., Sikka, S. C., & Hellstrom, W. J. G. (1999) · The Journal of Urology · doi:10.1097/00005392-199904010-00819 · Cited by 8
Self-citationTe, N., Bryan, W., Templeton, L. E., Sikka, S. C., & Hellstrom, W. J. G. (2001) · PubMed · Cited by 8
Self-citationBenson, G. S. (1991) · The Journal of Urology · doi:10.1016/s0022-5347(17)47805-0 · Cited by 8
Newhall, P., Traish, A. M., & Moreland, R. B. (1998) · International Journal of Impotence Research · doi:10.1038/sj.ijir.3900309 · Cited by 4
Research works printed but not linked: 3
- Balazy M et al. Vivinal nitrohydroxyeicosatrienoic acids: new vasodilator lipids formed from nitrogen dioxide and arachidonic acid Circulation 1999 100: I8–I14
- Ernster L . Lipid peroxidation in biological membranes: mechanisms and implications In: Yagi K, ed Active oxygen, lipid peroxides and antioxidants. CRC Press: Boca Raton, FL 1993 pp 1–38
- Hasche-Klunder R . Treatment of Peyronie's disease using para-aminobenzoate potassium (Potaba) Urologie 1978 17: 224–227
Cited by
Valente, E. G. A., Vernet, D., Ferrini, M. G., Qian, A., Rajfer, J., & Gonzalez-Cadavid, N. F. (2003) · Nitric Oxide · doi:10.1016/j.niox.2003.12.002 · Cited by 223
Mechanisms of Disease: new insights into the cellular and molecular pathology of Peyronie's disease
Gonzalez-Cadavid, N. F., & Rajfer, J. (2005) · Nature Clinical Practice Urology · doi:10.1038/ncpuro0201 · Cited by 168
Pryor, J., Akkus, E., Alter, G., Jordan, G., Lebret, T., Levine, L., Mulhall, J., Perovic, S., Ralph, D., & Stackl, W. (2004) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2004.10116.x · Cited by 149
Oboh, G., Ademiluyi, A. O., Ademosun, A. O., Olasehinde, T. A., Oyeleye, S. I., Boligon, A. A., & Athayde, M. L. (2015) · Biochemistry Research International · doi:10.1155/2015/175950 · Cited by 143
“Hydroxyl radical (OH) is highly reactive, energetic, shortlived, and very toxic to cells [26].”
BackgroundTaylor, F. L., & Levine, L. A. (2007) · Urologic Clinics of North America · doi:10.1016/j.ucl.2007.08.017 · Cited by 151
Metadata
- Authors
- Sikka, S. C., & Hellstrom, W. J. G.
- Affiliations
- Tulane University (US)
- Corresponding author
- Sikka, S C
- Venue
- International Journal of Impotence Research
- Published
- 2002-10-01
- Volume
- 14
- Issue
- 5
- Pages
- 353-360
- ISSN
- 0955-9930 (ISSN-L)
- 1476-5489
- OpenAlex
- W2333967808
- Cited by
- 77
- References
- 51
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 6 · 2023: 6 · 2022: 5 · 2021: 4 · 2020: 3 · 2019: 3 · 2018: 5 · 2017: 4 · 2016: 3 · 2015: 3 · 2014: 3 · 2013: 2 · 2012: 2
- FWCI
- 0.50
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- International Journal of Impotence Research (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Rheumatology › Dupuytren's Contracture and Treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Sexual function and dysfunction studies
- Health Sciences › Medicine › Urology › Urological Disorders and Treatments
- Keywords
- Peyronie's disease, oxidative stress, antioxidants, multimodal therapy
- MeSH terms
- Animals, Antioxidants, Humans, Male, Penile Induration, Reactive Oxygen Species, Oxidative Stress
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.